Shire, a global biotech specialist in rare diseases, announced that Thomas Dittrich will join the company as CFO and become an executive member of the Board of Directors and a member of the executive committee.
Dittrich will assume his roles at Shire in early 2018 following a transition period from his current employer.
“Thomas's wealth of experience while leading the finance teams at numerous multinational companies, including Amgen for several years, will be a tremendous asset for Shire as we continue to execute as the leading global biotech focused on rare diseases,” said Dr Flemming Ornskov, CEO at Shire.
“His unique financial skillset and results-oriented mentality make him the right person to lead Shire's finance function.”
Dittrich is currently CFO and a member of the executive committee at Sulzer, a publicly listed, global industrial engineering and manufacturing company.
He joined Sulzer in August 2014, serving as CEO and interim between August 2015 and December 2015.
At Sulzer, he was instrumental in designing the company's transformation programme and drove key upgrades to finance and IT functions, as well as to capital structure and resource allocation initiatives.
Prior to joining Sulzer, Dittrich served as VP of Finance Corporate Planning and Chief Accounting Officer of Amgen between 2010 and 2014.
Between 2006 and 2010, he was VP of Finance and Chief Financial Officer of Amgen International.
Dittrich also spent eight years with Dell, here he held various finance and general manager roles.
Earlier in his career, Dittrich worked at Booz & Co and Helbing Management Consulting in operational and merger and acquisition roles, respectively.
“Thomas is a talented global executive who will bring to Shire a broad range of experiences from both inside and outside the pharmaceutical industry,” said Susan Kilsby, Chairman of the Board at Shire.
“The Board and I look forward to working with him during this transformational time in the Company's history.”
“I am thrilled to join Shire at such an exciting time in the Company's evolution,” said Thomas Dittrich.
“I look forward to working with the Board, the Executive Committee and the Finance organisation as we build upon Shire's strong fundamentals to drive future growth and shareholder value.”
